과제정보
The study was supported by grants from the National Research Foundation of Korea (NRF-2015K1A4A3046807, NRF-2019M3A9H110358211, and NRF-2020M3A9E4036527), Asan Institute for Life Sciences, Korea (2020IP0021 and 2021P0018-1), Ministry of Health and Welfare of Korea (HI16C1559) and Ministry of Trade, Industry & Energy (MOTIE, Korea, Alchemist Project 20012378).
참고문헌
- Mather H, Nisbet JA, Burton G et al (1979) Hypomagnesaemia in diabetes. Arch Med Res 95, 235-242
- Caballero AEJAomr (2005) Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res 36, 241-249 https://doi.org/10.1016/j.arcmed.2005.03.013
- Mellitus D (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28, S5-S10
- Lebovitz HE (1999) Type 2 diabetes: an overview. Clin Chem 45, 1339-1345 https://doi.org/10.1093/clinchem/45.8.1339
- Leahy JL (2005) Pathogenesis of type 2 diabetes mellitus. Arch Med Res 36, 197-209 https://doi.org/10.1016/j.arcmed.2005.01.003
- Robertson RP, Zhou H, Zhang T and Harmon JS (2007) Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys 48, 139-146 https://doi.org/10.1007/s12013-007-0026-5
- Kieffer TJ, Woltjen K, Osafune K, Yabe D and Inagaki N (2018) Beta-cell replacement strategies for diabetes. J Diabetes Investig 9, 457-463 https://doi.org/10.1111/jdi.12758
- Suchy F, Yamaguchi T and Nakauchi H (2018) iPSC-derived organs in vivo: challenges and promise. Cell Stem Cell 22, 21-24 https://doi.org/10.1016/j.stem.2017.12.003
- Nakagawa M, Koyanagi M, Tanabe K et al (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26, 101-106 https://doi.org/10.1038/nbt1374
- Okano H, Nakamura M, Yoshida K et al (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112, 523-533 https://doi.org/10.1161/CIRCRESAHA.111.256149
- Park J, Lee Y, Shin J et al (2019) Mitochondrial genome mutations in mesenchymal stem cells derived from human dental induced pluripotent stem cells. BMB Rep 52, 689
- Reardon W, Pembrey M, Trembath R et al (1992) Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340, 1376-1379 https://doi.org/10.1016/0140-6736(92)92560-3
- Park CB and Larsson N-GJJocb (2011) Mitochondrial DNA mutations in disease and aging. J Cell Biol 193, 809-818 https://doi.org/10.1083/jcb.201010024
- Wallace DC (1994) Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci U S A 91, 8739-8746 https://doi.org/10.1073/pnas.91.19.8739
- Maechler P and Wollheim CBJN (2001) Mitochondrial function in normal and diabetic β-cells. Nature 414, 807-812 https://doi.org/10.1038/414807a
- Ryan CMJNoa (2005) Diabetes, aging, and cognitive decline. Neurobiol Aging 26, 21-25 https://doi.org/10.1016/j.neurobiolaging.2005.09.006
- Kang E, Wang X, Tippner-Hedges R et al (2016) Age-related accumulation of somatic mitochondrial DNA mutations in adult-derived human iPSCs. Cell Stem Cell 18, 625-636 https://doi.org/10.1016/j.stem.2016.02.005
- Ziada AS, Lu MY, Ignas-Menzies J et al (2019) Mitochondrial DNA somatic mutation burden and heteroplasmy are associated with chronological age, smoking, and HIV infection. Aging Cell 18, e13018
- Plecita-Hlavata L, Jaburek M, Holendova B et al (2020) Glucose-stimulated insulin secretion fundamentally requires H2O2 signaling by NADPH oxidase 4. Diabetes 69, 1341-1354 https://doi.org/10.2337/db19-1130
- MacDonald PE, El-kholy W, Riedel MJ, Salapatek AMF, Light PE and Wheeler MB (2002) The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 51, S434-S442 https://doi.org/10.2337/diabetes.51.2007.S434
- Ma H, Folmes CD, Wu J et al (2015) Metabolic rescue in pluripotent cells from patients with mtDNA disease. Nature 524, 234-238 https://doi.org/10.1038/nature14546
- Li S, Pan H, Tan C et al (2018) Mitochondrial dysfunctions contribute to hypertrophic cardiomyopathy in patient iPSC-derived cardiomyocytes with MT-RNR2 mutation. Stem Cell Rep 10, 808-821 https://doi.org/10.1016/j.stemcr.2018.01.013
- Hatakeyama H and Goto Y (2016) Concise review: heteroplasmic mitochondrial DNA mutations and mitochondrial diseases: toward iPSC-based disease modeling, drug discovery, and regenerative therapeutics. Stem Cells 34, 801-808 https://doi.org/10.1002/stem.2292
- Suzuki Y, Muramatsu T, Taniyama M et al (1996) Mitochondrial aldehyde dehydrogenase in diabetes associated with mitochondrial tRNALeu (UUR) mutation at position 3243. Diabetes Care 19, 1423-1425 https://doi.org/10.2337/diacare.19.12.1423
- Rorsman P and Braun MJArop (2013) Regulation of insulin secretion in human pancreatic islets. Annu Rev Physiol 75, 155-179 https://doi.org/10.1146/annurev-physiol-030212-183754
- Kristinsson H, Smith DM, Bergsten P and Sargsyan EJE (2013) FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion. Endocrinology 154, 4078-4088 https://doi.org/10.1210/en.2013-1352
- Choi JY, Jung JH, Shin S, Kim YH and Han DJJPO (2017) Association between the pancreas transplantation and survival of patients with diabetes: a single center experience. PLoS One 12, e0186827
- Shepherd RK, Checcarelli N, Naini A, De Vivo DC, DiMauro S and Sue CM (2006) Measurement of ATP production in mitochondrial disorders. J Inherit Metab Dis 29, 86-91 https://doi.org/10.1007/s10545-006-0148-8
- Kennedy ED, Maechler P and Wollheim CB (1998) Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. Diabetes 47, 374-380 https://doi.org/10.2337/diabetes.47.3.374